Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis.
Xiang W, He H, Duan X, He Z, Xu X, Liao M, Teng F, Li X, Luo T, Zeng J, Yu L, Gao C.
Xiang W, et al. Among authors: he h, he z.
Microbiol Spectr. 2023 Sep 12;11(5):e0472122. doi: 10.1128/spectrum.04721-22. Online ahead of print.
Microbiol Spectr. 2023.
PMID: 37698416
Free PMC article.